Learn More
Medchemexpress LLC MG-2119 | 1065500-40-4 | 99.7% | C27H29N5O4 | 10MG

Supplier: Medchemexpress LLC HY13930710MG
MG-2119 is a small-molecule inhibitor that blocks monomeric tau and alpha-synuclein aggregation. It is supplied as a high-purity research compound intended for preclinical studies probing neurodegenerative disease mechanisms and aggregation-targeted screening. The compound is compatible with common biochemical and cell-based assay workflows when prepared according to standard laboratory protocols.
- High purity suitable for research assays.
- Inhibits tau and alpha-synuclein aggregation in vitro.
- Available in multiple small-scale pack sizes for screening.
- Soluble in DMSO for solution preparation.
- Provides structural data (SMILES) and molecular weight for cheminformatics.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.